Trial Details

WITHDRAWN
Basic Information
Clinical ID c3346
Identifier NCT02190526
Trial Title Effects of Mesalamine and Amitriptyline on Irritable Bowel Syndrome
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Diarrhea- Predominant Irritable Bowel Syndrome|Quality of Life
Interventions DRUG: Mesalazine(asacol 800 mg)|DRUG: Amitriptyline|DRUG: placebo like asacol|DRUG: placebo like amitriptyline
Participant Information
Sponsor Tehran University of Medical Sciences
City Tehran Province
Country/Region Iran
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2014-09
Primary Completion Date 2015-12
Completion Date 2015-12